The next tier of EGFR resistance mutations in lung cancer
Hannah L. Tumbrink, Alena Heimsoeth, Martin L. Sos
Topics & Concepts
BiologyDruggabilityLung cancerOsimertinibProtein kinase domainDrug resistanceEpidermal growth factor receptorMutationGefitinibCancer researchMutantAdenocarcinomaCancerEGFR inhibitorsComputational biologyBioinformaticsGeneticsGeneErlotinibOncologyMedicineLung Cancer Treatments and MutationsCancer therapeutics and mechanismsQuinazolinone synthesis and applications